Christina Nicolodi
International Regulatory Affairs Consulting Services

Image
The past years have seen a dramatic increase in the level of development of innovative, advanced medicinal products.
Especially medicinal products for people with rare diseases often require the development of unique biological products.
Also the recent global threat with CoV-2 poses a huge challenge for the population and the pharmaceutical industry.

As Senior Regulatory Affairs professional with more than 15 years experience in global Regulatory Affairs, clinical development and quality assurance for biotechnological and Advanced Therapy Medicinal Products (ATMPs) I am supporting small enterprises developing novel products and those who needs Regulatory Affairs support in planning their first developmental steps.